Skip to main content
FinSpry Logo
FinSpry
NEO logo
NEO
(NASDAQ)
NeoGenomics, Inc.
$17.38-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeoGenomics (NEO) Stock Price & Financial Analysis

NeoGenomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.87 - $17.47
52-Week High$19.76
52-Week Low$7.07
Open$17.20
Volume996.86K
Average Volume (3M)2.20M
Market Cap2.27B
Shares Outstanding130.83M
Price to Sales (P/S)2.97
Price to Book (P/B)2.89
EV/EBITDA-21389.27
Revenue (TTM)766.29M
Net Income (TTM)-51.88M
Free Cash Flow (TTM)-7.36M
EPS (TTM)$-0.50
Profit Margin-6.77%
Operating Margin-8.63%
Return on Equity (ROE)-6.60%
Debt to Equity0.48
50-Day MA$15.62
200-Day MA$11.66
52-Week Change117.79%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 17, 2020

Frequently Asked Questions About NeoGenomics

What is the current stock price for NEO?

As of the latest trading session, NEO stock trades at $17.38. The 52-week range is $7.07–$19.76, with a day range of $16.86–$17.47.

What is the P/E ratio for NEO?

The P/E ratio (Price-to-Earnings) for NEO is shown in the Key Statistics section. This valuation metric helps compare NeoGenomics, Inc. to industry peers.

Does NEO pay dividends?

NeoGenomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NEO?

Based on 5 analysts, the consensus for NEO is Buy.

What is the market cap of NEO?

NeoGenomics's market capitalization is $2.27B, classifying it as a mid-cap company. NeoGenomics operates in the Healthcare sector within the Diagnostics & Research industry.